(Total Views: 90)
Posted On: 04/24/2024 12:10:50 PM
Post# of 15

$CGEM News Article - Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024 | Benzinga https://marketwirenews.com/news-releases/cull...05740.html


My Twitter: WhyteStocks